What We're Reading: Page 274
Industry reads hand-picked by our editors
Mar 27, 2018
Mar 26, 2018
Mar 23, 2018
-
Bloomberg
A $158 billion drug giant faces an identity crisis
-
The Wall Street Journal
Health-care firms turn to drugmaker executives as businesses converge
-
Reuters
CVS appoints former Eli Lilly CFO as president of PBM business
-
Kaiser Health News
Poll: Americans aghast over drug costs but aren’t holding their breath for a fix
Mar 22, 2018
Mar 21, 2018
-
Reuters
GlaxoSmithKline prescribes commercial reboot for pharma division
-
Regulatory Focus
FDA invites draft guidance on patient-focused drug development
-
The Wall Street Journal
A GOP right-to-try fumble
Mar 20, 2018
-
MIT Technology Review
AI can spot signs of Alzheimer’s before your family does
-
NPR
Shingles is nasty, and the new vaccine works well. Why do adults avoid shots?
-
The Boston Globe
Is Boston biotech in a bubble?
-
Bloomberg Gadfly
Beware biotech IPOs bearing Alzheimer's retreads
Previous
